The NF-κB pathway is downstream of the PI3K/AKT signaling pathway, acting as a master regulator of inflammatory responses, and its abnormal activation is a key pathogenic factor for the development of NAFLD/NASH [36,37]. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatohepatitis.